Skip to main content
. 2023 Mar 28;14:1116057. doi: 10.3389/fimmu.2023.1116057

Table 3.

HPD evaluation of 5 patients with Amp11q13 receiving immunotherapy.

Patient ID Line TTF<2 months TGK TGR Tumor Burden Increase% HPD
31 2 yes 7.91 6.2 593.667 yes
29 1 yes 579.527 yes
25 1 yes 35.1115 no
23 1 yes 9.41931 no
26 1 yes 53.4903 yes